Scientific & Regulatory Consulting•Toxicology & Product Safety
Request basket0
PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Diethylenetriaminepentaacetate→

Diethylenetriaminepentaacetate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
14047-41-7
Molecular formula
C14H18N3O10-5
Molecular weight
388.31 g/mol
Drug class
Pentetic acid (DTPA)metal chelator and decorporation agent
Mechanism of action
Forms stable complexes with selected trivalent and divalent metal ions, including plutonium, americium and curium, promoting their excretion in urine. Calcium-DTPA and zinc-DTPA are the authorised decorporation salts; the free acid is not interchangeable by dose.
Indications / reported uses
  • Treatment to enhance elimination of internal contamination with plutonium, americium or curium following known or suspected radioactive contamination, using the appropriate calcium-DTPA or zinc-DTPA formulation under specialist radiation-emergency guidance

Sources: US FDA — Pentetate calcium trisodium and pentetate zinc trisodium product information · CDC — DTPA medical countermeasure guidance · FDA product information

View request basketPrefer email? [email protected]
PDE / ADE derivationOEL derivationOEB / OHC bandingRequest basket0
Substance information

Drug class, mechanism of action and general use cases

Drug class

Pentetic acid (DTPA); metal chelator and decorporation agent

Mechanism of action

Forms stable complexes with selected trivalent and divalent metal ions, including plutonium, americium and curium, promoting their excretion in urine. Calcium-DTPA and zinc-DTPA are the authorised decorporation salts; the free acid is not interchangeable by dose.

General use cases

  • Treatment to enhance elimination of internal contamination with plutonium, americium or curium following known or suspected radioactive contamination, using the appropriate calcium-DTPA or zinc-DTPA formulation under specialist radiation-emergency guidance

For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.

Assessment scope

Project-specific PDE/ADE and OEL/OEB support

Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.

  • PDE/ADE: critical effects, point of departure and justified adjustment factors.
  • OEL: inhalation hazards, exposure duration and workplace conditions.
  • OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
  • Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope

PDE/ADE and OEL/OEB assessment

ReguSight provides project-specific support for Diethylenetriaminepentaacetate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Diethylenetriaminepentaacetate Permitted Daily Exposure (PDE) report (the Diethylenetriaminepentaacetate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Diethylenetriaminepentaacetate Occupational Exposure Limit (OEL) report (the Diethylenetriaminepentaacetate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.